Human kidney thiopurine methyltransferase. Photoaffinity labeling with S-adenosyl-L-methionine
- PMID: 1510725
- DOI: 10.1016/0006-2952(92)90416-g
Human kidney thiopurine methyltransferase. Photoaffinity labeling with S-adenosyl-L-methionine
Abstract
Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of heterocyclic and aromatic sulfhydryl compounds such as the thiopurine drug 6-mercaptopurine (6-MP). TPMT activity in human tissue is regulated by a common genetic polymorphism, and "pharmacogenetic" variation in TPMT activity is an important factor in individual differences in thiopurine drug metabolism, toxicity and therapeutic efficacy. Human renal tissue contains two isozymes of TPMT, Peak I and Peak II, that can be separated by ion exchange chromatography. Our experiments were performed to determine whether S-adenosyl-L-methionine (Ado-Met), the methyl donor for the TPMT reaction, could be used as a photoaffinity ligand for these isozymes as one step in the study of the molecular basis for the TPMT genetic polymorphism. When [3H-methyl]Ado-Met and partially purified preparations of either isozyme of human kidney TPMT were exposed to ultraviolet light at 254 nm, followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a 35 kDa protein was the predominant species that was radioactively labeled. The same 35 kDa protein was photoaffinity labeled with [14C-carboxyl]Ado-Met, demonstrating that labeling involved covalent binding of Ado-Met rather than methylation of the protein. TPMT enzymatic activity co-eluted with the 35 kDa protein during sequential DEAE ion exchange, gel filtration and hydroxylapatite chromatography. Inhibitors of TPMT enzymatic activity including S-adenosyl-L-homocysteine, sinefungin, 6-methylmercaptopurine and 3,4-dimethoxy-5-hydroxybenzoic acid inhibited photoaffinity labeling of the 35 kDa protein in preparations of both TPMT Peak I and Peak II isozymes in a concentration-dependent fashion, as did 6-MP, the methyl acceptor substrate for the TPMT reaction. All of these results were compatible with the conclusion that the 35 kDa protein was TPMT. Photoaffinity labeling of TPMT with [3H]Ado-Met should make it possible to purify the enzyme to homogeneity and to study amino acid sequences at or near its active site.
Similar articles
-
Thiopurine methyltransferase isozymes in human renal tissue.Drug Metab Dispos. 1990 Sep-Oct;18(5):632-8. Drug Metab Dispos. 1990. PMID: 1981712
-
Thiopurine methyltransferase: mouse kidney and liver assay conditions, biochemical properties and strain variation.Biochem Pharmacol. 1985 Nov 1;34(21):3823-30. doi: 10.1016/0006-2952(85)90430-7. Biochem Pharmacol. 1985. PMID: 4062957
-
Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.Mol Pharmacol. 1993 Jun;43(6):878-87. Mol Pharmacol. 1993. PMID: 8316220
-
Methylation pharmacogenetics: thiopurine methyltransferase as a model system.Xenobiotica. 1992 Sep-Oct;22(9-10):1055-71. doi: 10.3109/00498259209051860. Xenobiotica. 1992. PMID: 1441597 Review.
-
Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms.Mutat Res Rev Mutat Res. 2021 Jul-Dec;788:108396. doi: 10.1016/j.mrrev.2021.108396. Epub 2021 Oct 7. Mutat Res Rev Mutat Res. 2021. PMID: 34893161 Free PMC article. Review.
Cited by
-
Thiopurine methyltransferase predicts the extent of cytotoxicty and DNA damage in astroglial cells after thioguanine exposure.PLoS One. 2011;6(12):e29163. doi: 10.1371/journal.pone.0029163. Epub 2011 Dec 21. PLoS One. 2011. PMID: 22216194 Free PMC article.
-
Pharmacogenetics of cancer therapy: getting personal.Am J Hum Genet. 1998 Jul;63(1):11-6. doi: 10.1086/301941. Am J Hum Genet. 1998. PMID: 9634537 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous